The novel enterovirus protease inhibitor (PI) SG85 effectively inhibits the replication of 14 rhinoviruses representative of species A and B (median 50% effective concentration, 0. (3Cpro) is usually a promising focus on for drug advancement efforts due to the advanced of conservation in its substrate-binding site, its function as an essential enzyme for pathogen replication,… Continue reading The novel enterovirus protease inhibitor (PI) SG85 effectively inhibits the replication